Medical News

RSS

Merz Pharma Group granted early termination in connection with BioForm Medical share tender offer

Merz Pharma Group today announced that it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by Merz GmbH & Co. KGaA (“Merz”) and its acquisition subsidiary to purchase all outstanding shares of common stock of BioForm Medical, Inc..

3 Feb 2010

Veran Medical Technologies receives two FDA clearances to expand the use of ig4 Navigation platform

Veran Medical Technologies announced today that it has recently received two clearances (K093146 & K093995) from the U.S. Food and Drug Administration (FDA) to expand its indications for use of the ig4 Navigation platform.

3 Feb 2010

Ohio changes Medicaid drug program, N.C. weighs cuts in Medicaid personal care services

The Cleveland Plain Dealer reports that Ohio's seven Medicaid managed care plans this month will make changes in the prescription drug plans that cover about 1.5 million people, although many of those beneficiaries will not face increased costs.

3 Feb 2010

Study could provide potential therapeutic strategies for treating prostate cancer

Prostate cancer cells are more likely to spread to other parts of the body if a specific gene quits functioning normally, according to new data from researchers at UT Southwestern Medical Center.

3 Feb 2010

Vizioncore makes $500 donation to fight breast cancer

Vizioncore Inc. today announced the company is making a $500 donation to 26.2 with Donna - The National Marathon to Finish Breast Cancer. The charitable organization is the only U.S. marathon dedicated solely to raising funds to end breast cancer.

3 Feb 2010

EpiCept regains compliance with Nasdaq minimum bid price requirement

EpiCept Corporation today announced that Nasdaq notified the Company that it has regained compliance with the minimum bid price requirement in Listing Rule 5550(a)(2) and met the requirements of the Nasdaq Listing Qualification Panel (the “Panel”) decision dated November 2, 2009. Accordingly, the Panel has determined to continue the listing of the Company’s common stock on The Nasdaq Stock Market.

3 Feb 2010

Research thesis hopes to lift the veil on the practice of forced marriages

Sakina (fictitious name) was born in Bangladesh yet raised in Montreal. At 16, she returned to her homeland with her parents under the pretext of visiting her sick grandmother. The young woman was then forced to marry a man twice her age - despite her resistance.

3 Feb 2010

U.S. government to reimburse American hospitals that treat airlifted Haitian patients

"The federal government announced on Monday that it would reimburse American hospitals who treat Haitian earthquake victims with life-threatening injuries, making it possible for more hospitals in states outside Florida to consider taking those patients," the New York Times reports.

3 Feb 2010

Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.

From Fluxion Biosciences 3 Feb 2010

Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement

Suneva Medical, a privately-held aesthetic medical device company, today announced that two clinical studies suggest Artefill may be a safe, effective, long-term treatment option for age-related and HIV lipoatrophy patients.

3 Feb 2010

Research suggests growth factor gene plays a central role in palate development

Cleft palate has been linked to dozens of genes. During their investigation of one of these genes, researchers at Washington University School of Medicine in St. Louis were surprised to find that cleft palate occurs both when the gene is more active and when it is less active than normal.

3 Feb 2010

VIDAZA prolongs survival in AML patients

The Myelodysplastic Syndromes (MDS) Foundation says a study published this week in the Journal of Clinical Oncology concludes VIDAZA (azacitidine) “prolongs survival and is well tolerated” in patients with acute myeloid leukemia (AML) - an aggressive form of leukemia that in many cases progresses from MDS.

3 Feb 2010

Tenet Healthcare signs multi-year agreement with MultiPlan

Tenet Healthcare Corporation today announced that it signed a multi-year agreement with MultiPlan, Inc., effective Jan. 1, 2010. The agreement includes participation in the PHCS (formerly Private Healthcare Systems) Network, the MultiPlan Network and, in select markets, PHCS Savility, which is MultiPlan’s newest primary PPO network.

3 Feb 2010

CSC, ALS TDI extend collaboration in advancing potential stem cell therapy for ALS

California Stem Cell, Inc. (CSC) and ALS Therapy Development Institute (ALS TDI) are pleased to announce an extension and expansion of their collaboration aimed at advancing a potential stem cell therapy for ALS (amyotrophic lateral sclerosis). This effort will build on work that has already been completed as part of this on-going partnership to understand how stem cells, and their derivatives, may be applied to treatment of this fatal neurodegenerative disease.

3 Feb 2010

Students collect money to support vital cancer research initiatives

Millions of students across the country soon will share more than their "two cents" as they collect spare change to benefit The Leukemia & Lymphoma Society's (LLS) School & Youth campaign during Olive Garden's 16th-annual Pasta for Pennies program.

3 Feb 2010

Women of Baycrest to find answers: why women are more vulnerable to Alzheimer's disease than men

"Beat Brain Sag: Ladies, Give Your Grey Matter a Lift!" is an event for both women and men who want to take charge of their lives before cognitive decline takes charge of them. Presented by the Women of Baycrest in partnership with Baycrest's Aging, Innovation & the Mind Speaker Series, the event will be held Wednesday, February 10, 2010, 7 p.m., at The Guvernment.

3 Feb 2010

ALEC commends Kansas legislators for filing Health Care Freedom Amendment

The American Legislative Exchange Council (ALEC) — the nation's largest nonpartisan individual membership association of state legislators — congratulates Kansas State Senator Mary Pilcher Cook and Representatives Peggy Mast and Brenda Landwehr for filing the Kansas Health Care Freedom Amendment, which would protect the right of individuals to make their own health care choices.

3 Feb 2010

Fat tissue in PCOS patients may predispose them to diabetes and heart disease

Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, according to a study conducted at the Center for Androgen-Related Research and Discovery at Cedars-Sinai Medical Center.

3 Feb 2010

Some states restart health reforms while others push back

"Lawmakers in at least two states, California and Missouri, have introduced legislation for the current session to create government-backed coverage for state residents," The Wall Street Journal reports.

3 Feb 2010

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that sales of its recently launched over-the-counter pain reliever, Cobroxin, totaled $583,955 for the fourth quarter ending December 31, 2009.

3 Feb 2010

Medical News

Merz Pharma Group granted early termination in connection with BioForm Medical share tender offer

Veran Medical Technologies receives two FDA clearances to expand the use of ig4 Navigation platform

Ohio changes Medicaid drug program, N.C. weighs cuts in Medicaid personal care services

Study could provide potential therapeutic strategies for treating prostate cancer

Vizioncore makes $500 donation to fight breast cancer

EpiCept regains compliance with Nasdaq minimum bid price requirement

Research thesis hopes to lift the veil on the practice of forced marriages

U.S. government to reimburse American hospitals that treat airlifted Haitian patients

Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit

Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement

Research suggests growth factor gene plays a central role in palate development

VIDAZA prolongs survival in AML patients

Tenet Healthcare signs multi-year agreement with MultiPlan

CSC, ALS TDI extend collaboration in advancing potential stem cell therapy for ALS

Students collect money to support vital cancer research initiatives

Women of Baycrest to find answers: why women are more vulnerable to Alzheimer's disease than men

ALEC commends Kansas legislators for filing Health Care Freedom Amendment

Fat tissue in PCOS patients may predispose them to diabetes and heart disease

Some states restart health reforms while others push back

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News